OBJECTIVE: To introduce effectiveness of tumor treating fields (TTFields), how to care for the patient with this type of treatment, and the critical role the nurse plays in educating the patient about this innovative treatment. DATA SOURCES: Published research and articles in both nursing and medical journals. CONCLUSION: TTFields are an antimitotic therapy delivered via transducer arrays that are worn on the scalp to treat newly diagnosed and recurrent glioblastoma, the most aggressive primary brain cancer. Oncology nurses are integral in educating and supporting the patient in its use and managing its of treatment. IMPLICATIONS FOR NURSING PRACTICE: Nurses are on the front line of educating the patient, caregivers, and the larger body of clinicians who deliver care to these patients. Education provided by nurses increases the patients' knowledge, and thus compliance, as well as the overall outcome through proper usage of TTFields.
OBJECTIVE: To introduce effectiveness of tumor treating fields (TTFields), how to care for the patient with this type of treatment, and the critical role the nurse plays in educating the patient about this innovative treatment. DATA SOURCES: Published research and articles in both nursing and medical journals. CONCLUSION: TTFields are an antimitotic therapy delivered via transducer arrays that are worn on the scalp to treat newly diagnosed and recurrent glioblastoma, the most aggressive primary brain cancer. Oncology nurses are integral in educating and supporting the patient in its use and managing its of treatment. IMPLICATIONS FOR NURSING PRACTICE: Nurses are on the front line of educating the patient, caregivers, and the larger body of clinicians who deliver care to these patients. Education provided by nurses increases the patients' knowledge, and thus compliance, as well as the overall outcome through proper usage of TTFields.
Authors: Yin Qiu Tan; Yun Tao Li; Teng Feng Yan; Yang Xu; Bao Hui Liu; Ji An Yang; Xue Yang; Qian Xue Chen; Hong Bo Zhang Journal: Front Immunol Date: 2020-12-21 Impact factor: 7.561